Edge Therapeutics Files for $115 Million
Edge Therapeutics, which is developing formulations of existing therapies for ruptured brain aneurysms, filed on Friday with the SEC to raise up to $115 million in an initial public offering.
The Berkeley Heights, NJ-based company, which was founded in 2009, plans to list on the Nasdaq under the symbol EDGE. Edge Therapeutics initially filed confidentially on 3/21/2014. Leerink Partners and Credit Suisse are the joint bookrunners on the deal. No pricing terms were disclosed.
Help employers find you! Check out all the jobs and post your resume.
The Berkeley Heights, NJ-based company, which was founded in 2009, plans to list on the Nasdaq under the symbol EDGE. Edge Therapeutics initially filed confidentially on 3/21/2014. Leerink Partners and Credit Suisse are the joint bookrunners on the deal. No pricing terms were disclosed.
Help employers find you! Check out all the jobs and post your resume.